Sector portfolio · Asset manager · United States

Perceptive Advisors' Biotech portfolio

Perceptive Advisors has backed 101 Biotech startups in rounds we track, $24B between them, shown by the stage each has reached. The best-funded is Bridgebio.

101startups backed
4stages
$24Braised between them
Stage not reportedbiggest stage

Perceptive Advisors's whole portfolioPerceptive Advisors's profile

Stage not reported

39

+15 more

Series C and later

27

+3 more

Series B

20

Series A

15

Segment by segment

Stage not reported

39 startups · $11B raised

  1. BridgeBioBridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.United States$1.4B
  2. Apogee TherapeuticsApogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.United States$1.3B
  3. Oruka TherapeuticsOruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.United States$880M
  4. Spyre TherapeuticsSpyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.United States$678M
  5. IDEAYA BiosciencesIDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.United States$608M
  6. FreenomeFreenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.United States$553M
  7. CTCerevel TherapeuticsCerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.United States$450M
  8. Taysha Gene TherapiesTaysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.United States$400M

Series C and later

27 startups · $7.9B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
  3. ZymergenUnited States$874M
  4. Avidity BiosciencesSynapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.United States$790M
  5. Orchard TherapeuticsOrchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.United Kingdom$377M
  6. Outset MedicalOutset Medical is a medical technology company that offers reimagining dialysis for patients and providers.United States$360M
  7. Solid BiosciencesSolid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.United States$333M
  8. Beta BionicsBeta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.United States$296M

Series B

20 startups · $4.0B raised

  1. Akero TherapeuticsAkero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.United States$502M
  2. CTCidara TherapeuticsCidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.United States$463M
  3. SpringWorks TherapeuticsSpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.United States$400M
  4. Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.United States$322M
  5. Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
  6. Stoke TherapeuticsStoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.United States$255M
  7. Marea TherapeuticsMarea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.United States$190M
  8. scPharmaceuticalsScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.United States$187M

Series A

15 startups · $1.8B raised

  1. Nuvation BioNuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.United States$675M
  2. CPCinCor PharmaCinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.United States$275M
  3. Kronos BioKronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.United States$123M
  4. Merida BiosciencesMerida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autUnited States$121M
  5. Axonis TherapeuticsAxonis Therapeutics is a Boston-based biotechnology company founded in 2019, focused on developing innovative oral therapies for nUnited States$115M
  6. AAavantiBioAavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.-$107M
  7. Fusion PharmaceuticalsFusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.Canada$85M
  8. OncorusOncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.United States$77M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Perceptive Advisors as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioPerceptive Advisors' Pharma portfolio18 startups · $2.5BPortfolio mapPerceptive Advisors portfolio map133 startups · $28BCo-investorsWho invests with Perceptive Advisors116 co-investorsSector portfolioBlackRock's AI portfolio41 startups · $529BSector portfolioBlackRock's Fintech portfolio25 startups · $17BSector portfolioBlackRock's Biotech portfolio19 startups · $4.2B

Raising from investors like Perceptive Advisors?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps